Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

570
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
570
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

448
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
448
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.0K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.0K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

493
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
493

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased Incident Sensorineural Hearing Loss Among Individuals With Varicose Veins: A Multi-Institution Cohort Study.

Angiology·2025
Same author

Ramsay-Hunt Syndrome.

Journal of cutaneous medicine and surgery·2024
Same author

A structured approach with Swiss cheese model to reduce vascular adverse events of filler injections.

Journal of cosmetic dermatology·2023
Same author

Risk of incident cataract in patients with psoriasis: A population-based cohort study.

The Journal of dermatology·2021
Same author

Acquired epidermodysplasia verruciformis or generalized verrucosis? A clinical and virological comparative study.

The Journal of dermatology·2021
Same author

First report of histopathological and ultrasonographic correlation of localized lichen myxoedematosus.

Clinical and experimental dermatology·2021

Related Experiment Video

Updated: Jul 1, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

383

Risks of glaucoma among individuals with psoriasis: a population-based cohort study.

Shu-Hao Li1, Chun-Yu Cheng1,2,3

  • 1Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Clinical and Experimental Dermatology
|March 12, 2024
PubMed
Summary

Patients with psoriasis face a higher risk of developing glaucoma. Long-term psoralen-ultraviolet A (PUVA) therapy further increases this risk, highlighting the need for vigilant eye monitoring.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.9K
Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

3.1K

Related Experiment Videos

Last Updated: Jul 1, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

383
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.9K
Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

3.1K

Area of Science:

  • Ophthalmology
  • Dermatology
  • Systemic Autoimmune Diseases

Background:

  • Psoriasis is a chronic inflammatory condition with known systemic implications.
  • Ocular manifestations are increasingly recognized in patients with psoriasis.

Purpose of the Study:

  • To investigate the association between psoriasis and the subsequent risk of glaucoma.
  • To explore the impact of specific psoriasis treatments on glaucoma risk.

Main Methods:

  • A large-scale cohort study utilizing the Chang Gung Research Database (2003-2012).
  • Matched controls (1:4 ratio) were used for comparison.
  • Cox regression analysis estimated hazard ratios for glaucoma.
  • Evaluated risks associated with systemic therapies, phototherapy, and topical corticosteroids.

Main Results:

  • 6,682 psoriasis patients and 26,728 controls were analyzed.
  • Psoriasis patients exhibited a significantly higher incidence rate of glaucoma (aHR 1.405).
  • Psoralen-ultraviolet A (PUVA) therapy exceeding 200 sessions correlated with elevated glaucoma risk.

Conclusions:

  • Individuals diagnosed with psoriasis demonstrate an increased risk of developing glaucoma.
  • Prolonged exposure to PUVA therapy is a significant risk factor for glaucoma in psoriasis patients.